Tizanidine Hydrochloride Capsule
Product Images NDC 50742-225

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Tizanidine Hydrochloride (NDC 50742-225). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Ingenus Pharmaceuticals, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Tizanidine Structure (49d0fb0e 9403 4e99 Bf59 01b9a45a7dde 01)

FDA Label Image

Figure 1 (49d0fb0e 9403 4e99 Bf59 01b9a45a7dde 02)

FDA Label Image

Figure 2 (49d0fb0e 9403 4e99 Bf59 01b9a45a7dde 03)

FDA Label Image

Figure 3 (49d0fb0e 9403 4e99 Bf59 01b9a45a7dde 04)

The text describes the improvement in Ashworth Score for a medication called Tizanidine, with a mean dose of 26.8mg. The results are presented in a table with scores for the end of titration, the end of maintenance, and the endpoint of the study, at Week 3 and Week 7. The last observation carried forward method was used for the endpoint score.*

FDA Label Image

Tizanidine Hydrochloride Capsules 2 mg Bottle Label (49d0fb0e 9403 4e99 Bf59 01b9a45a7dde 05)

FDA Label Image

Tizanidine Hydrochloride Capsules 4 mg Bottle Label (49d0fb0e 9403 4e99 Bf59 01b9a45a7dde 06)

FDA Label Image

Tizanidine Hydrochloride Capsules 6 mg Bottle Label (49d0fb0e 9403 4e99 Bf59 01b9a45a7dde 07)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.